Cargando…
Differences between the non-steroidal aromatase inhibitors anastrozole and letrozole – of clinical importance?
Aromatase inhibition is the gold standard for treatment of early and advanced breast cancer in postmenopausal women suffering from an estrogen receptor-positive disease. The currently established group of anti-aromatase compounds comprises two reversible aromatase inhibitors (anastrozole and letrozo...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068499/ https://www.ncbi.nlm.nih.gov/pubmed/21364577 http://dx.doi.org/10.1038/bjc.2011.58 |